Loading company…
Proteint provides multi-omics testing and chronic disease management services.
Established in 2014, Proteint provides multi-omics testing services for oncology and cardiology, using genomics, proteomics, and metabolomics platforms. It also offers chronic disease management based on nuclear magnetic resonance testing. The company is based in Tianjin, China, and established a medical testing lab in 2016.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in